Kyu Yeoun Won

Kyu Yeoun Won

Auto-generated profile, based on publicly available information

Kyu Yeoun Won

Department of Pathology, Kyung Hee University Hospital at Gangdong, Seoul, Korea

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
KWKyu Yeoun Won
Kyu Yeoun Won
SMSun Young Min
Sun Young Min
JSJeong-Yoon Song
Jeong-Yoon Song
SLSung-Jig Lim
Sung-Jig Lim
SHSang Ah Han
Sang Ah Han
Won KY, et al. J Breast Cancer. 2021 Feb;24(1):34-48. https://doi.org/10.4048/jbc.2021.24.e12

1 April 2020 in Ultrasonography
Verified
Journal Article
Open access
DYDal Mo Yang
Dal Mo Yang
HKHyun Cheol Kim
Hyun Cheol Kim
SKSang Won Kim
Sang Won Kim
KWKyu Yeoun Won
Kyu Yeoun Won
Groin lesions can be classified as neoplastic or non-neoplastic. Neoplastic lesions include lipoma, epidermoid cyst, angiomyofibroblastoma-like tumor, liposarcoma, and synovial sarcoma, as well as metastases from lymphoma, neuroendocrine carcinoma, and carcinomas of the lung, breast, urinary bladder, ovary, vulva, and colon. Non-neoplastic lesions include hernias, round ligament varices, endometriosis, Kimura disease, Castleman disease, hematoma, and inflammation. Because the clinical implications and therapeutic strategies for groin lesions vary depending on the cause, the ability to noninvasively differentiate among etiologies is very important. Although there is substantial overlap in ultrasonographic findings across various groin lesions, some ultrasonographic features, along with clinical characteristics, may suggest a specific diagnosis. Familiarity with the ultrasonographic and clinical features of various groin lesions facilitates accurate diagnosis and treatment.

1 January 2024 in Journal of the Korean Society of Radiology
Verified
Journal Article
Open access
PDF file
SLSe Jin Lee
Se Jin Lee
DYDal Mo Yang
Dal Mo Yang
HKHyun Cheol Kim
Hyun Cheol Kim
SKSang Won Kim
Sang Won Kim
KWKyu Yeoun Won
Kyu Yeoun Won
WJWoo Kyoung Jeong
Woo Kyoung Jeong
이세진, et al. J Korean Soc Radiol. 2024 Jan;85(1):109-123. https://doi.org/10.3348/jksr.2023.0026

4 November 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MKMin Seob Kwak
Min Seob Kwak
JCJae Myung Cha
Jae Myung Cha
CKChang Woo Kim
Chang Woo Kim
KWKyu Yeoun Won
Kyu Yeoun Won
CHChang-il Hwang
Chang-il Hwang
Understanding and accurate diagnosis of lymph node metastasis (LNM) for patients with colorectal cancer (CRC) is essential to determine treatment and follow-up strategies. Therefore, in this study, we aimed to elucidate the biological process and identify the potential biomarker for LNM in CRC. A total of 30 patients who received a histologically confirmed diagnosis of CRC with Stage I to III and a curative surgery between November 2020 and July 2021 at Kyung Hee university hospital at Gangdong were included. We performed multi-omics approach integrating the data on somatic mutation, transcriptomic expression, DNA methylation, and microbiome with tumor and adjacent matched normal tissues of each patient. In total, 12 significant DEGs between the patients with and without LNM were identified, consisting of significantly upregulated S100A8 gene, a proinflammatory gene. The GSEA revealed that gene sets involving “MULTI CANCER INVASIVENESS” in terms related to epithelial-mesenchymal transition was significantly upregulated in the patients with LNM. Integrated functional analysis of DNA methylation with transcriptome profile shows that significantly hypomethylated promoters of the genes are enriched for LNM. The phylum Proteobacteria, unassigned ( p _PU) presented significantly higher proportions in cancer tissues from the adjacent normal tissues. Notably, when compared to the patients without LNM, the gut microbiota of those with LNM appears to exhibit a significantly lower abundance of the p _PU, indicating its potential as promising biomarker for LNM in CRC. We explained the mechanism of tumor spreading using multi-omics analysis and identified the relevant metagenomic biomarker to predict the LNM in CRC by the recognition of host-microbial interaction, thereby can make the cancer surveillance of the patients more individualized and convincing.

1 January 2016 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
SCSun-Hee Choi
Sun-Hee Choi
SHSang Ah Han
Sang Ah Han
KWKyu Yeoun Won
Kyu Yeoun Won
Choi SH, et al. J Korean Med Sci. 2016 Feb;31(2):321-325. http://dx.doi.org/10.3346/jkms.2016.31.2.321

1 March 2016 in The Journal of Rheumatology
Verified
Journal Article
Open access
PDF file
KWKyu Yeoun Won
Kyu Yeoun Won
SPSo Young Park
So Young Park
SLSang Hoon Lee
Sang Hoon Lee